Table 1 Clinical characteristics of UCEC patients in training and testing cohorts.

From: A novel mitochondrial-related risk model for predicting prognosis and immune checkpoint blockade therapy response in uterine corpus endometrial carcinoma

Clinical Characteristics

Training cohort

Testing cohort

P value

No.

271

272

 

Age

 ≤ 60

103 (38.0%)

104 (38.2%)

0.956

 > 60

168 (62.0%)

168 (61.8%)

Histological type

 Endometrioid

200 (73.8%)

207 (76.1%)

0.644

 Serous

58 (21.4%)

56 (20.6%)

 Mixed

13 (4.8%)

9 (3.3%)

Stage

 I

160 (59.0%)

179 (65.8%)

0.255

 II

30 (11.1%)

22 (8.1%)

 III

63 (23.2%)

60 (22.1%)

 IV

18 (6.6%)

11 (4.0%)

Grade

 G1

45 (16.6%)

54 (19.9%)

0.778

 G2

61 (22.5%)

59 (21.7%)

 G3

160 (59.0%)

153 (56.3%)

 G4

5 (1.8%)

6 (2.2%)